BioMérieux: Jennifer Zinn
BioMérieux has appointed Jennifer Zinn as executive VP of clinical operations, effective Aug. 1. Zinn succeeds Pierre Boulud, who was recently appointed BioMérieux's CEO.
Zinn joined BioMérieux in October as general manager and head of clinical operations for North America and led the effort to prepare the US launch of the BioFire SpotFire, BioMérieux’s multiplex PCR system designed for decentralized point-of-care clinical settings. Previously, Zinn served as executive VP and head of diagnostics for North America at Siemens Healthineers, led commercial operations for North America at Roche Diagnostics, and worked in commercial operations at Ortho Clinical Diagnostics.